Regulation of Dendritic Cell Migration to the Draining Lymph Node
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Antigen-pulsed dendritic cells (DCs) are used as natural adjuvants for vaccination, but the factors that influence the efficacy of this treatment are poorly understood. We investigated the parameters that affect the migration of subcutaneously injected mouse-mature DCs to the draining lymph node. We found that the efficiency of DC migration varied with the number of injected DCs and that CCR7+/+ DCs migrating to the draining lymph node, but not CCR7-/- DCs that failed to do so, efficiently induced a rapid increase in lymph node cellularity, which was observed before the onset of T cell proliferation. We also report that DC migration could be increased up to 10-fold by preinjection of inflammatory cytokines that increased the expression of the CCR7 ligand CCL21 in lymphatic endothelial cells. The magnitude and quality of CD4+ T cell response was proportional to the number of antigen-carrying DCs that reached the lymph node and could be boosted up to 40-fold by preinjection of tumor necrosis factor that conditioned the tissue for increased DC migration. These results indicate that DC number and tissue inflammation are critical parameters for DC-based vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mouse DCs start to enter the regional lymph node 18 hours after inoculation in the skin, reaching a maximum within 72 hours.50,51”
From Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells (2006) · cites this paper as [50]
Experimental — accuracy not yet measuredIn the citing paper
“besides their critical role for priming T cells in lymph nodes (Martin-Fontecha et al., 2003)”
From Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12 (2018) · cites this paper as Martin-Fontecha et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336 · cited 1×
“Tissue-resident DCs and DC precursors, such as monocytes or immature DCs recruited from the blood, are stimulated by microbial products and inflammatory cytokines to undergo a coordinately regulated process of maturation and migration (1).”
The Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410 · cited 1×
“The finding that DC migration can be boosted by inflammatory stimuli through up-regulation of CCL21 on lymphatic endothelial cells was unexpected, because CCL21 has been considered the prototype of constitutive chemokines (27).”
Förster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-Müller, I., Wolf, E., & Lipp, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80059-8 · Cited by 2,367 · cited 5×
“Lack of CCR7 or its ligands leads to dramatic changes in DC and lymphocyte traffic and abnormal lymph node architecture (8, 9).”
InfluentialSelf-citationAlteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690 · cited 5×
“The fact that CCR7 / DCs, which are incapable of migrating to the lymph node, do not cause lymph node congestion indicates that this phenomenon is mediated by mature DCs that have reached the lymph node through mechanisms that still need to be identified but might be related to release of chemokines or S1P.”
InfluentialDieu, M.-C., Vanbervliet, B., Vicari, A., Bridon, J.-M., Oldham, E., Aït-Yahia, S., Brière, F., Zlotnik, A., Lebecque, S., & Caux, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.373 · Cited by 1,425 · cited 1×
“Immature DCs express receptors for inflammatory chemokines and, upon induction of maturation, up-regulate CCR7, a chemokine receptor that drives their migration to the lymphatics (2, 3).”
Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M. C., & Steinman, R. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021598 · Cited by 1,306
Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation
Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin, S., & Lanzavecchia, A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199809)28:09<2760::aid-immu2760>3.0.co;2-n · Cited by 1,183 · cited 1×
“Immature DCs express receptors for inflammatory chemokines and, upon induction of maturation, up-regulate CCR7, a chemokine receptor that drives their migration to the lymphatics (2, 3).”
Gunn, M. D., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa, A., Williams, L. T., & Nakano, H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.451 · Cited by 1,019 · cited 2×
“In plt/plt mice, which carry a spontaneous mutation that abolishes CCL19 expression and restricts CCL21 expression to the lymphatic endothelium, DCs and naive T cells fail to enter the T cell zone of secondary lymphoid organs (9, 10).”
Gunn, M. D., Tangemann, K., Tam, C., Cyster, J. G., Rosen, S. D., & Williams, L. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.258 · Cited by 1,001
Kurts, C., Kosaka, H., Carbone, F. R., Miller, J. F. A. P., & Heath, W. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.239 · Cited by 706
Cited by
Items 601–700 of 888
Monasterio, G., Guevara, J., Ibarra, J. P., Castillo, F. A., Díaz‐Zúñiga, J., Álvarez, C., Cafferata, E. A., & Vernal, R. (2018) · Clinical Oral Investigations · doi:10.1007/s00784-018-2641-5 · Cited by 13
Park, J., Wu, C. T., & Bryers, J. D. (2012) · Immunology · doi:10.1111/imm.12056 · Cited by 14
Cytokine Modulation of the Innate Immune Response in Feline Immunodeficiency Virus–Infected Cats
Dean, G. A., LaVoy, A. S., Yearley, J. H., & Stanton, C. (2006) · The Journal of Infectious Diseases · doi:10.1086/503873 · Cited by 13
“Enlargement occurs within 1 day and peaks at 3–4 days, and the degree of enlargement is related to the number of activated DCs in the LN [49].”
BackgroundLi, X., Han, Y., & Sun, E. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.02.023 · Cited by 13
Modeling the TB/HIV-1 Co-Infection and the Effects of Its Treatment
Magombedze, G., Garira, W., & Mwenje, E. (2010) · Mathematical Population Studies · doi:10.1080/08898480903467241 · Cited by 13
“The term r TSTBE TBE+NbE represents (i) the priming of naive and precursor T cells to effector T cells, (ii) the recruitment of precursor T cells from the DLN which are further primed at the site of infection (Marino and Kirschner, 2004; Langenkamp, Messi, Lanzavecchia, and Sallusto, 2000; Martin-Fontecha et al., 2003…”
BackgroundChen, Q., Sen, G., & Snapper, C. M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6044 · Cited by 13
“Thus, IL-1 enhances CCL21 expression on endothelial cells and promotes entry of DC into lymph nodes with subsequent enhanced T cell priming (55).”
BackgroundRetractedFunctional Specialization of Dendritic Cell Subsets
Heidkamp, G. F., Lehmann, C. H. K., Heger, L., Baransk, A., Hoffmann, A., Lühr, J. J., & Dudziak, D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30076-1 · Cited by 16
Lee, S. M., Lee, J., Kim, D., Avila, J. P., Nakaya, H. I., Kwak, K., & Kim, E. H. (2025) · npj Vaccines · doi:10.1038/s41541-025-01130-z · Cited by 14
The role of lymphoid tissue in the attenuation of the postoperative ileus
Koscielny, A. J., Engel, D. R., Maurer, J., Wehner, S., Kurts, C., & Kalff, J. C. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00161.2012 · Cited by 12
Granuloma Transplantation: An Approach to Study Mycobacterium?Host Interactions
Harding, J. S., Schreiber, H. A., & Sándor, M. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00245 · Cited by 13
“…requires donor CCR7 (responsible for migration of DCs to secondary lymphoid organs; Cyster, 1999; Randolph, 2001; Frontiers in Microbiology | Cellular and Infection Microbiology December 2011 | Volume 2 | Article 245 | 4 Martin-Fontecha et al., 2003) from acute granulomas, but not chronic ones.”
BackgroundSachdeva, M., Sharma, A., & Arora, S. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140852 · Cited by 12
“In one study conducted in mice, DCs from a CCR7−/− animals failed to to migrate to draining lymph nodes, indicating the role of CCR7 in this process [33].”
BackgroundLymphocyte Trafficking to Mucosal Tissues
Mikhak, Z., Agace, W. W., & Luster, A. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-415847-4.00040-9 · Cited by 13
Yuan, L., Chen, X., Di, Y., & Liu, M.-L. (2017) · International Journal of Ophthalmology · doi:10.18240/ijo.2017.06.06 · Cited by 12
Langerhans Cells Control Lymphatic Vessel Function during Inflammation via LIGHT-LTβR Signaling
Wang, Z., Wang, W., Chai, Q., & Zhu, M. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801578 · Cited by 13
Langerhans Cells and Other Skin Dendritic Cells
Teunissen, M. B. M. (2004) · CRC Press eBooks · doi:10.1201/b14248-10 · Cited by 12
Pizzurro, G. A., Tapia, I. J., Sganga, L., Podhajcer, O. L., Mordoh, J., & Barrio, M. M. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1743-z · Cited by 11
A Stable Chemokine Gradient Controls Directional Persistence of Migrating Dendritic Cells
Quast, T., Zölzer, K., Guu, D., Alvarez, L., Küsters, C., Kiermaier, E., Kaupp, U. B., & Kolanus, W. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.943041 · Cited by 12
“However, recent studies with Dictyostelium amoeba suggest that these cells employ both sensing modalities and that an interplay between cellular memory and adaptive temporal sensing allows cells to maintain their direction when the guidance cue fluctuates (Huang and Iglesias, 2014; Nakajima et al., 2014; Skoge et al.,…”
BackgroundMethodInfluentialLint, S. V., Parys, A. V., Eeckhout, B. V. D., Vandamme, N., Plaisance, S., Verhee, A., Catteeuw, D., Rogge, E., Geest, J. D., Vanderroost, N., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01908-6 · Cited by 12
“An unpaired nonparametric Mann–Whitney t-test ( A ) or parametric t-test ( D ) was performed depending on Shapiro Wilk normality test * < 0.05; ** < 0.01; *** < 0.001; **** < 0.0001 with the extent of T cell proliferation and effector cell differentiation [38].”
MethodInfluentialLee, H. J., Ko, J. H., Ko, A. Y., Kim, M. K., Wee, W. R., & Oh, J. Y. (2014) · Current Eye Research · doi:10.3109/02713683.2013.877489 · Cited by 11
Antigen‐loaded ER microsomes from APC induce potent immune responses against viral infection
Sofra, V., Mansour, S., Liu, M., Gao, B., Primpidou, E., Wang, P., & Li, S. (2008) · European Journal of Immunology · doi:10.1002/eji.200838443 · Cited by 11
“The sustained accumulation of antigen-carrying microsomes in the peripheral lymphoid organs explains the high efficacy of induced responses in vivo [ 18 ].”
BackgroundKadayakkara, D. K. K., Korrer, M. J., Bulte, J. W. M., & Levitsky, H. I. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0820 · Cited by 11
“The magnitude of the T-cell response to vaccination is thought to be in part dependent on the magnitude of antigen delivery to DLN by appropriately matured APCs (13).”
BackgroundIngersoll, M. A., Potteaux, S., Álvarez, D., Hutchison, S. B., van Rooijen, N., & Randolph, G. J. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.05.014 · Cited by 11
Djuretić, J., Dimitrijević, M., Stojanović, M., Stevuljević, J. K., Hamblin, M. R., Micov, A. M., Stepanović-Petrović, R. M., & Leposavić, G. (2021) · Scientific Reports · doi:10.1038/s41598-021-81999-7 · Cited by 12
Frattolin, J., Watson, D., Bonneuil, W. V., Russell, M. J., Masci, F. F., Bandara, M., Brook, B. S., Nibbs, R. J. B., & Moore, J. E. (2021) · Cells · doi:10.3390/cells10123439 · Cited by 15
Adrenoceptors as Potential Target for Add-On Immunomodulatory Therapy in Multiple Sclerosis
Pilipović, I., Stojić-Vukanić, Z., & Leposavić, G. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108358 · Cited by 12
Ontiveros, F., Wilson, E. B., & Livingstone, A. M. (2011) · Immunology · doi:10.1111/j.1365-2567.2010.03400.x · Cited by 11
Ozawa, Y., Suda, T., Nagata, T., Hashimoto, D., Nakamura, Y., Enomoto, N., Inui, N., Koide, Y., Nakamura, H., & Chida, K. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0446oc · Cited by 13
Immune surveillance and anti-tumor immune responses: an anatomical perspective
Zimmermann, V. S., Benigni, F., & Mondino, A. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.09.005 · Cited by 11
Cognate Antigen Stimulation Generates Potent CD8+ Inflammatory Effector T Cells
Sung, H. C., Lemos, S., dos Santos, P. R., Kozyrytska, K., Vasseur, F., Legrand, A., Charbit, A., Rocha, B., & Evaristo, C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00452 · Cited by 11
“This notion issued from the demonstration that TNF induces the up-regulation of Sphk1 expression in certain cell lines in vitro.”
BackgroundInfluentialHoen, E. N. M. N., Boot, E. P. J., Wagenaar-Hilbers, J. P. A., van Bilsen, J. H. M., Arkesteijn, G. J. A., Storm, G., Everse, L. A., van Eden, W., & Wauben, M. H. M. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607436 · Cited by 12
“During active disease (Day 35), CD134CD25 effector/memory T cells, strongly reacting to disease-associated antigen, were found in peripheral blood and PLN, which may be explained by the suggested capacity of effector/memory T cells to migrate to inflamed LN [49].”
de Heusch, M., Garzé, V., Maliszewski, C. R., Urbain, J., Liu, Y., & Moser, M. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.05.009 · Cited by 11
A Novel Cellular Pathway of Antigen Presentation and CD4 T Cell Activation in vivo
Scales, H. E., Meehan, G. R., Hayes, A. J., Benson, R. A., Watson, E., Walters, A., Tomura, M., Maraskovsky, E., Garside, P., Morelli, A. B., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02684 · Cited by 11
Intratumoural administration of dendritic cells: hostile environment and help by gene therapy
Huarte, E., Tirapu, I., Arina, A., Vera, M., Alfaro, C., Murillo, O., Palencia, B., Busto, V., Marín, V., Mazzolini, G. D., et al. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.1.7 · Cited by 12
“CCL19 and CCL21 are the ligands for CCR7 [130], the main chemokine receptor that drives mature DCs to lymphoid tissue [133].”
BackgroundVaccine strategies to treat lymphoproliferative disorders
Radford, K. J., Vari, F., & Hart, D. N. J. (2005) · Pathology · doi:10.1080/00313020500376462 · Cited by 11
MPI region of interest (ROI) analysis and quantification of iron in different volumesPreprint
Sehl, O. C., Tiret, B., Berih, M. A., Makela, A. V., Goodwill, P. W., & Foster, P. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.10.487778 · Cited by 11
“MPI can be used to track and quantify adoptive cells as they move within the body by first labeling them with SPIONs in vitro [1]–[4].”
BackgroundNagaoka, K., Nakanishi, H., Tanaka, H., Anindita, J., Kawamura, T., Tanaka, T., Yamashita, T., Kuroda, A., Nomura, S., Akita, H., et al. (2025) · Gastric Cancer · doi:10.1007/s10120-025-01640-8 · Cited by 10
“In contrast, ex vivo-generated DC vaccines may lack efficient homing to lymphoid tissues [17, 18].”
Conventional type I migratory CD103+ dendritic cells are required for corneal allograft survival
Blanco, T., Singh, R. B., Nakagawa, H., Taketani, Y., Dohlman, T. H., Chen, Y., Chauhan, S. K., Yin, J., & Dana, R. (2023) · Mucosal Immunology · doi:10.1016/j.mucimm.2022.12.002 · Cited by 10
Fanning, L. B., Buckley, C., Xing, W., Breslow, R. G., & Katz, H. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057007 · Cited by 10
“Expression of CCL21 on lymphatic endothelium is upregulated by mediators associated with inflammation, such as TNF-a, IL-1a [30] lymphotoxin-a1b2 [42,43], and Oncostatin M [28].”
BackgroundInfluentialLee, H.-J., Lee, H., Lee, Y. L., Jeon, Y. H., Jeong, S. Y., Lee, S., Lee, J., & Ahn, B. (2017) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1127-1 · Cited by 10
“The high density of cells at the injection site may prevent the access to sufficient oxygen and nutrients, therefore it may hamper the cell movement and active migration [17].”
BackgroundInfluentialGroft, S. G., Nagy, N., Boom, W. H., & Harding, C. V. (2020) · Infection and Immunity · doi:10.1128/iai.00323-20 · Cited by 11
“of IL-12 production in DCs may promote priming of Th1 responses and DC migration to draining lymph nodes (39, 41, 42).”
BackgroundAltered Chemokine Receptor Profile on Circulating Leukocytes in Human Heart Failure
Athanassopoulos, P., Vaessen, L. M. B., Balk, A. H. M. M., Weimar, W. W., SHARMA, H. S., & Bogers, A. J. J. C. (2006) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:44:1:083 · Cited by 11
“cells to lymphoid tissues for T-helper (Th)1 or Th2 priming during end-stage HF (Fig. 8). In this state, lymph nodes could play a central role in T cell and dendritic cell (DC) homing, because lymphatic endothelial cells have been shown to increase CCL-21 (secondary lymphoid tissue chemokine) expression upon precondit…”
BackgroundIdentification and characterization of allergens:in vitroapproaches
Basketter, D. A., & Maxwell, G. (2007) · Expert Review of Dermatology · doi:10.1586/17469872.2.4.471 · Cited by 10
Wirsdörfer, F., Bangen, J., Pastille, E., Hansen, W., & Flohé, S. B. (2015) · Clinical Science · doi:10.1042/cs20140835 · Cited by 11
Wang, G., Yoon, D., Nandi, A., Patel, K., Azar, T., Kim, J., Han, N. A., Nickie, A., Park, S., Wang, K., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.12.004 · Cited by 12
Dendritic Cell-Based Vaccination for Renal Cell Carcinoma: Challenges in Clinical Trials
Wang, J., Liao, L., & Tan, M. J. (2012) · Immunotherapy · doi:10.2217/imt.12.107 · Cited by 9
Preconditioning Vaccine Sites for mRNA-Transfected Dendritic Cell Therapy and Antitumor Efficacy
Batich, K. A., Swartz, A. M., & Sampson, J. H. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3387-7_47 · Cited by 9
Styles, T. M., Gangadhara, S., Reddy, P. B. J., Sahoo, A., Shiferaw, A., Welbourn, S., Kozlowski, P. A., Derdeyn, C. A., Velu, V., & Amara, R. R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.914969 · Cited by 9
Detecting apoptosis of leukocytes in mouse lymph nodes
Gómez, L., Delgado-Martín, C., López-Cotarelo, P., Escribano‐Diaz, C., Alonso‐Colmenar, L. M., Riol‐Blanco, L., & Rodríguez‐Fernández, J. L. (2014) · Nature Protocols · doi:10.1038/nprot.2014.078 · Cited by 9
From optical bench to cageside: intravital microscopy on the long road to rational vaccine design
Hickman, H. D., Bennink, J. R., & Yewdell, J. W. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00973.x · Cited by 9
“CCR7’s ligands, CCL19 and CCL21, are expressed by both lymphatic endothelial cells and LN cells, and lymphatic endothelial expression is greatly increased by inflammation (29).”
BackgroundImpact of CCR7 on the gastrointestinal field effect
Koscielny, A. J., Engel, D. R., Maurer, J., Hirner, A., Kurts, C., & Kalff, J. C. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00224.2010 · Cited by 10
“CCR7 / dendritic cells are thought to migrate to draining lymph nodes after activation (10, 18, 25, 30, 44, 46, 52, 53, 60, 64, 85) to activate and react with T cells (7, 17, 19, 28, 31, 34, 51, 58, 74, 75), which then enter peripheral tissues to perform immune effector functions (5, 17, 19, 29, 31, 34, 53, 73, 90, 91…”
BackgroundMiyagaki, T., Sugaya, M., Okochi, H., Asano, Y., Tada, Y., Kadono, T., Blauvelt, A., Tamaki, K., & Sato, S. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.135 · Cited by 9
Control of TNF-Induced Dendritic Cell Maturation by Hybrid-Type N-Glycans
Schlickeiser, S., Stanojlović, S., Appelt, C., Vogt, K., Vogel, S., Haase, S., Ritter, T., Volk, H., Pleyer, U., & Sawitzki, B. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003410 · Cited by 9
“In vivo, we detected significantly fewer IFN-g–secreting alloreactive T cells in mice receiving TNF-a–stimulated allogeneic, kifunensine-pretreated DCs, which was at least a consequence of greatly reduced numbers of mature cells that could be recruited from the site of injection to lymphoid organs to prime naive T cel…”
BackgroundLina, L., TAKAHASHI, T. T., Ide, I., & Murase, H. (2008) · IEICE Transactions on Information and Systems · doi:10.1093/ietisy/e91-d.4.1091 · Cited by 9
Antibody-Mediated Delivery of Antigen to Dendritic Cells
Pugholm, L. H., & Varming, K. (2016) · Immunotherapy Open Access · doi:10.4172/2471-9552.1000119 · Cited by 9
“Arriving in the secondary lymphoid tissues, Ag-bearing DCs efficiently trigger an immune response by T cells that recognize one of the antigenic peptides presented in complex with a MHC molecule on the DC surface membrane [17].”
BackgroundDell, K., Klein, C., & Gissmann, L. (2008) · Antiviral Therapy · doi:10.1177/135965350801300409 · Cited by 9
Khamisabadi, M., Arab, S., Motamedi, M., Khansari, N., Moazzeni, S. M., Gheflati, Z., & Hadjati, J. (2008) · PubMed · doi:10.22034/iji.2008.17098 · Cited by 9
Sinking while you swim: A dual role for CCR7 in leukocyte migration
Donnelly, H., Mandrou, E., & Insall, R. H. (2023) · Science Immunology · doi:10.1126/sciimmunol.adj3102 · Cited by 8
Ouologuem, L., & Bartel, K. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1389194 · Cited by 9
Kojima, N., Kato, C., Igarashi, M., & Ishii, M. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.07.013 · Cited by 8
Fink, C., Smith, M. H., Sehl, O. C., Gaudet, J. M., Meagher, T. C., Sheikh, N. A., Dikeakos, J. D., Rieder, M. J., Foster, P. J., & Dekaban, G. A. (2020) · Diagnostic and Interventional Imaging · doi:10.1016/j.diii.2020.02.004 · Cited by 9
“Pre-treatment of the draining pLN with IL-1 before adoptive cell transfer was also included to improve in vivo PFC+ PBMC migration as a means of enhancing immunotherapeutic effectiveness [15,23,35].”
BackgroundMethodHow B cells drive T-cell responses: A key role for cross-presentation of antibody-targeted antigens
OSSENDORP, F. A., Ho, N. I., & van Montfoort, N. (2023) · Advances in immunology · doi:10.1016/bs.ai.2023.09.002 · Cited by 10
Mucosal Immune Responses in W/Wv and Sl/Sld Mutant Mice
Yoshino, N., Kanno, H., Takahashi, K., Endo, M., & Sato, S. (2012) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.61.407 · Cited by 9
“Mast cells are required for the enhanced recruitment of lymphocytes and Langerhans cells to draining lymph nodes, which is required for the induction of acquired immune responses [27, 34, 35].”
BackgroundMatisz, C. E., Geuking, M. B., Lopes, F., Petri, B., Wang, A., Sharkey, K. A., & McKay, D. M. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.07.008 · Cited by 8
Shih, N., Yang, H., Cheng, H.-T., Hung, Y., Yao, Y., Zhu, Y.-H., Wu, Y., & Liu, K. (2009) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31819d29d8 · Cited by 8
“The increased DC migration led to T-cell responses that are of higher magnitude and more effective.(15) We are interested in evaluating the combination of gene-modified tumor cells with DC-based cancer vaccine as an improvement of current therapy.”
BackgroundHypomorphic mutation in the RAG2 gene affects dendritic cell distribution and migration
Maina, V., Marrella, V., Mantero, S., Cassani, B., Fontana, E., Anselmo, A., Prete, A. D., Sozzani, S., Vezzoni, P., Poliani, P. L., et al. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0713365 · Cited by 8
“though the injection of BM-DCs caused an increase in RAG2 / LN cellularity [38], RAG2 LN cell count remained low as in untreated mutants (Supplemental Fig.”
BackgroundParenteral Vaccine Administration: Tried and True
Johansen, P., & Kündig, T. M. (2014) · Advances in delivery science and technology · doi:10.1007/978-1-4939-1417-3_14 · Cited by 10
Roles of lymphoid cells in the differentiation of Langerhans dendritic cells in mice
Asli, B., Lantz, O. J., Santo, J. P. D., Saeland, S., & Geissmann, F. (2004) · Immunobiology · doi:10.1016/j.imbio.2004.05.002 · Cited by 9
The Dynamics of Dendritic Cell—Mediated Innate Immune Regulation
Ohteki, T. (2007) · Allergology International · doi:10.2332/allergolint.r-07-148 · Cited by 8
Cryogel‐Based Dendritic Cell Immunotherapy for Post‐Surgical Breast Cancer Treatment
Nguyen, L., Cheng, S., Yen, Y., Lee, H., Wu, T., Wang, J., Lin, S., & Chen, Y. (2025) · Advanced Science · doi:10.1002/advs.202503238 · Cited by 9
Gálvez‐Cancino, F., Roco, J. A., Rojas-Colonelli, N., Flores, C., Murgas, P., Cruz, S. R., Oyarce, C., Varas‐Godoy, M., Sauma, D., & Lladser, Á. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.06.041 · Cited by 7
“Other studies have also shown that pre-conditioning the vaccination site can significantly improve DC migration to the lymph nodes and efficacy of tumor antigen-loaded DC vaccines through a chemotaxis-dependent mechanism [44,45].”
BackgroundClonal Expansion of Allergen-specific CD4+T Cell in the Lung in the Absence of Lymph Nodes
Choi, G., Kim, B., Park, Y., Shim, I., & Chung, Y. (2017) · Immune Network · doi:10.4110/in.2017.17.3.163 · Cited by 8
“It is well-established that the clonal expansion of naïve T cells occurs in the draining lymph nodes since antigenbearing DCs migrate into the T cell zone of the lymph nodes by upregulating C-C chemokine receptor type 7 (8,9).”
Platt, A. M., & Randolph, G. J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-3235-7_4 · Cited by 7
Propranolol Impairs Primary Immune Responses in Rat Experimental Autoimmune Encephalomyelitis
Pilipović, I., Vujnović, I., Petrović, R., Stojić-Vukanić, Z., & Leposavić, G. (2019) · NeuroImmunoModulation · doi:10.1159/000500094 · Cited by 7
Krmeská, V., Aggio, J. B., Nylén, S., Wowk, P. F., & Rothfuchs, A. G. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100981 · Cited by 7
“enhances DC migration from that location to dLNs (16).”
BackgroundYi, D. H., Stetter, N., Jakobsen, K., Jonsson, R., & Appel, S. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2216-y · Cited by 7
Okada, N. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.1543 · Cited by 7
Principles of dendritic cell-based immunotherapy in myeloid leukemia
Westers, T. M., Houtenbos, I., van de Loosdrecht, A. A., & Ossenkoppele, G. J. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.06.003 · Cited by 7
The Dendritic Cell: The Immune System’s Adjuvant–A Strategy To Develop a HCV Vaccine?
Larsson, M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.049 · Cited by 7
Droebner, K., Klein, B., Paxian, S. A., Schmid, R. M., Stitz, L., & Planz, O. (2010) · Viral Immunology · doi:10.1089/vim.2009.0101 · Cited by 6
“CCL19 and CCL21 are crucial for the positioning of T cells and dendritic cells (DC) within the T-cell zones of secondary lymphoid organs (43,44, 67).”
Technical Challenges in the Manufacture of Dendritic Cell Cancer Therapies
Lozano, M. C. G., Cid, J., Benítez‐Ribas, D., & Juan, M. (2019) · European Oncology & Haematology · doi:10.17925/eoh.2019.15.1.22 · Cited by 6
Luker, A. J., Wukitch, A. M., Kulinski, J. M., Ganesan, S., Kabát, J., Lack, J., Frischmeyer‐Guerrerio, P. A., Metcalfe, D. D., & Olivera, A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1427509 · Cited by 6
Mécanismes immunologiques de l'immunothérapie sublinguale spécifique des allergènes
Overtvelt, L. V., Batard, T., Fadel, R., & Moingeon, P. E. (2006) · Revue Française d Allergologie et d Immunologie Clinique · doi:10.1016/j.allerg.2006.10.006 · Cited by 6
Lymphatic Vessels Enhancing Adaptive Immunity Deteriorates Renal Inflammation and Renal Fibrosis
Wu, J., Pei, G., Zeng, R., & Xu, G. (2020) · Kidney Diseases · doi:10.1159/000506201 · Cited by 6
Haseda, Y., Munakata, L., Kimura, C., Kinugasa‐Katayama, Y., Mori, Y., Suzuki, R., & Aoshi, T. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254628 · Cited by 7
Qu, Y., Rose, R. D., Kim, C., Zhou, J., Lin, Z., Ju, Y., Bhangu, S. K., Cortez‐Jugo, C., Cavalieri, F., & Caruso, F. (2023) · Angewandte Chemie · doi:10.1002/ange.202214935 · Cited by 6
Hu, Y., & Cauley, L. S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00227 · Cited by 6
Immunogenicity is preferentially induced in sparse dendritic cell cultures
Nasi, A., Bollampalli, V. P., Sun, M. Y., Chen, Y., Amu, S., Nylén, S., Eidsmo, L., Rothfuchs, A. G., & Réthi, B. (2017) · Scientific Reports · doi:10.1038/srep43989 · Cited by 7
Homeward Bound: How Do Skin Dendritic Cells Find Their Way into the Lymph System?
Hwang, S. T. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.39 · Cited by 6
“…elegant adoptive transfer experiments demonstrating that DCs from CCR7 KO mice fail to migrate to peripheral LNs after implantation in the subcutis (Martin-Fontecha et al., 2003), in fluorescein isothiocyanate (FITC)skin painting experiments (Foerster et al., 1999), and in experiments in which a…”
BackgroundMa, Y., Yang, M., He, Z., Fan, M., Huang, M., Teng, F., Wei, Q., & Li, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6448 · Cited by 6
“DC migration from peripheral tissues to secondary immune organs, particularly lymph nodes, is a prerequisite for initiating an effective immune response, and CCR7 expression at the surface of DCs facilitates homing (20,21).”
Jellmayer, J. A., de Deus, A. F., Gonçalves, M. R. C., Ferreira, L. S., Manente, F. A., Caetano, L. S. P., Piccineli, F. L., Genari, T. Z. D. R., Saçaki, B. D. C., Campos, T. P. C. D. O., et al. (2025) · Microorganisms · doi:10.3390/microorganisms13102351 · Cited by 5
Exploring cellular immunotherapy platforms in multiple myeloma
Vo, M.-C., Jung, S.-H., Nguyen, V., Tran, V.-D.-H., Ruzimurodov, N., Kim, S. K., Nguyen, X., Kim, M., Song, G., Ahn, S., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27892 · Cited by 18
“Third, only 4% of injected DCs migrate to the lymph nodes to perform their functions [156,157].”
BackgroundPark, J., & Bryers, J. D. (2012) · Immunology · doi:10.1111/imm.12059 · Cited by 5
Separate Roles for Antigen Recognition and Lymph Node Inflammation in CD8+ Memory T Cell Formation
Fransen, M. F., van Stipdonk, M. J. B., Sluijter, M., Schoenberger, S. P., Melief, C. J. M., & Offringa, R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904046 · Cited by 5
“Chemokines like CCL9 and CCL21, cytokines including TNF-alpha and IFN-α/β, and the chemo-attractant receptor S1P all play an important role in enhancing the cellularity of the lymph node during an immune response, thereby creating an inflammatory micro-environment supportive of T-cell priming.(3-8) The significance of…”
Choi, D. W., Jung, S. Y., Lee, S., Shon, D., & Shin, H. S. (2020) · Journal of Medicinal Food · doi:10.1089/jmf.2020.4767 · Cited by 5
“20,21 Therefore, we evaluated the effect of RMFE on Th2-related immune responses by measuring Th2 cytokine levels in dLNs.”
Nakawesi, J., Muleta, K. G., Dasoveanu, D., Johansson‐Lindbom, B., & Lahl, K. (2020) · European Journal of Immunology · doi:10.1002/eji.202048990 · Cited by 7
de Wit, M. C., Horzinek, M. C., Haagmans, B. L., & Schijns, V. E. C. J. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.09.014 · Cited by 5
Magombedze, G., Garira, W., & Mwenje, E. (2009) · International Journal of Biomathematics · doi:10.1142/s1793524509000534 · Cited by 5
Downregulation of Lymphatic Vessel Formation Factors in PGF2α-induced Luteolysis in the Cow
Nitta, A., Shirasuna, K., Nibuno, S., Bollwein, H., Shimizu, T., & Miyamoto, A. (2013) · Journal of Reproduction and Development · doi:10.1262/jrd.2012-090 · Cited by 5
Limitations of CD95 ligand‐transduced killer dendritic cells to prevent graft rejections
Kusuhara, M., & Matsue, H. (2005) · Experimental Dermatology · doi:10.1111/j.0906-6705.2005.00307.x · Cited by 5
Schiering, C., Guarnerio, J., Basso, V., Muzio, L., & Mondino, A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4398 · Cited by 5
“Finally, we investigated whether favoring the DC to T-cell ratio or the availability of peptide-MHC complexes on the DC surface, both known to determine the extent of CD4 T-cell priming (39, 40), could also improve T-cell priming.”
Background
Metadata
- Authors
- Martín-Fontecha, A., Sebastiani, S., Höpken, U. E., Uguccioni, M., Lipp, M., Lanzavecchia, A., & Sallusto, F.
- Affiliations
- 1Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland
- Institute for Research in Biomedicine (CH)
- 2Max Delbrück Center for Molecular Medicine, 13122 Berlin-Buch, Germany
- Max Delbrück Center (DE)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-08-18
- Volume
- 198
- Issue
- 4
- Pages
- 615-621
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2194169
- OpenAlex
- W2149057253
- Cited by
- 878
- References
- 29
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 16 · 2023: 24 · 2022: 15 · 2021: 28 · 2020: 27 · 2019: 31 · 2018: 33 · 2017: 37 · 2016: 39 · 2015: 28 · 2014: 29 · 2013: 57 · 2012: 30
- FWCI
- 16.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Science Foundation
- Institute for Research in Biomedicine
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (63885)
- Helmut Horten Stiftung
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- dendritic cell migration, draining lymph nodes, CCR7, CCL21, lymphatic endothelial cells, inflammatory cytokines, TNF-α, CD4+ T cell responses, antigen-pulsed dendritic cells, dendritic cell vaccine, lymph node cellularity, tissue inflammation
- MeSH terms
- Animals, Cell Movement, Dendritic Cells, Fluorescent Dyes, Humans, Interleukin-1, Lymph Nodes, Mice, Inbred BALB C, T-Lymphocytes, Tumor Necrosis Factor-alpha, Cell Transplantation, Receptors, Chemokine, Mice, Receptors, CCR7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.